[PHARMA] QoQ Annualized Quarter Result on 30-Sep-2019 [#3]

Stock
[PHARMA] PHARMANIAGA BHD
Announcement Date
20-Nov-2019
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2019
Quarter
30-Sep-2019 [#3]
Profit Trend
QoQ- -32.22%
YoY- -22.75%
Quarter Report
Latest QR
Upcoming QR
PHARMA's Result
PHARMA's Financial Summary
View:
Show?
Annualized Quarter Result
30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 CAGR
Revenue 2,931,368 3,279,684 2,820,530 2,806,462 2,775,996 3,144,432 2,384,956 14.75%
PBT 90,412 123,520 -191,865 62,145 85,448 120,972 70,220 18.37%
Tax -26,368 -33,860 42,418 -23,097 -27,628 -42,380 -26,990 -1.54%
NP 64,044 89,660 -149,447 39,048 57,820 78,592 43,230 29.98%
-
NP to SH 64,756 89,596 -149,219 39,172 57,796 78,468 42,468 32.51%
-
Tax Rate 29.16% 27.41% - 37.17% 32.33% 35.03% 38.44% -
Total Cost 2,867,324 3,190,024 2,969,977 2,767,414 2,718,176 3,065,840 2,341,726 14.46%
-
Net Worth 357,891 350,047 336,573 516,387 518,564 528,825 509,862 -21.03%
Dividend
30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 CAGR
Div 44,409 62,695 22,177 29,557 44,299 62,521 41,621 4.42%
Div Payout % 68.58% 69.98% 0.00% 75.46% 76.65% 79.68% 98.01% -
Equity
30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 CAGR
Net Worth 357,891 350,047 336,573 516,387 518,564 528,825 509,862 -21.03%
NOSH 261,705 261,229 261,229 261,229 261,229 260,505 260,505 0.30%
Ratio Analysis
30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 CAGR
NP Margin 2.18% 2.73% -5.30% 1.39% 2.08% 2.50% 1.81% -
ROE 18.09% 25.60% -44.33% 7.59% 11.15% 14.84% 8.33% -
Per Share
30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 CAGR
RPS 1,122.12 1,255.48 1,081.04 1,076.09 1,065.29 1,207.05 916.82 14.43%
EPS 24.78 34.28 -57.19 15.01 22.18 30.12 16.33 32.08%
DPS 17.00 24.00 8.50 11.33 17.00 24.00 16.00 4.12%
NAPS 1.37 1.34 1.29 1.98 1.99 2.03 1.96 -21.25%
Adjusted Per Share Value based on latest NOSH - 261,229
30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 CAGR
RPS 203.39 227.56 195.70 194.72 192.61 218.17 165.48 14.75%
EPS 4.49 6.22 -10.35 2.72 4.01 5.44 2.95 32.35%
DPS 3.08 4.35 1.54 2.05 3.07 4.34 2.89 4.34%
NAPS 0.2483 0.2429 0.2335 0.3583 0.3598 0.3669 0.3538 -21.04%
Price Multiplier on Financial Quarter End Date
30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 CAGR
Date 30/06/20 31/03/20 31/12/19 30/09/19 28/06/19 29/03/19 31/12/18 -
Price 2.22 1.26 2.06 2.44 2.84 2.27 2.78 -
P/RPS 0.20 0.10 0.19 0.23 0.27 0.19 0.30 -23.70%
P/EPS 8.96 3.67 -3.60 16.25 12.80 7.54 17.03 -34.85%
EY 11.17 27.22 -27.76 6.16 7.81 13.27 5.87 53.61%
DY 7.66 19.05 4.13 4.64 5.99 10.57 5.76 20.95%
P/NAPS 1.62 0.94 1.60 1.23 1.43 1.12 1.42 9.19%
Price Multiplier on Announcement Date
30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 CAGR
Date 19/08/20 19/05/20 20/02/20 20/11/19 23/08/19 16/05/19 21/02/19 -
Price 4.42 1.88 2.04 2.21 2.66 2.36 2.76 -
P/RPS 0.39 0.15 0.19 0.21 0.25 0.20 0.30 19.13%
P/EPS 17.83 5.48 -3.57 14.71 11.99 7.83 16.91 3.59%
EY 5.61 18.24 -28.04 6.80 8.34 12.76 5.92 -3.52%
DY 3.85 12.77 4.17 5.13 6.39 10.17 5.80 -23.92%
P/NAPS 3.23 1.40 1.58 1.12 1.34 1.16 1.41 73.86%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment